The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 09, 2016

Filed:

Sep. 20, 2006
Applicants:

Ralf Huss, Waakirchen, DE;

Peter J. Nelson, Munich, DE;

Inventors:

Ralf Huss, Waakirchen, DE;

Peter J. Nelson, Munich, DE;

Assignee:

Other;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/57 (2006.01); C07K 14/81 (2006.01); C07H 21/04 (2006.01); C12N 15/63 (2006.01); C12N 5/10 (2006.01); A61P 35/00 (2006.01); A61K 47/48 (2006.01);
U.S. Cl.
CPC ...
C07K 14/8146 (2013.01); A61K 47/48053 (2013.01); A61K 47/48238 (2013.01);
Abstract

The present invention relates to fusion constructs of glycosylphosphatidylinositol (GPI)-anchored tissue inhibitors of metalloproteinases (TIMPs) and their use for the treatment of cancer and in regenerative medicine. By this approach, the GPI-anchored TIMP proteins are incorporated into the surface membrane of tumor cells and render tumor cells sensitive to FAS-induced apoptosis. Furthermore, the fusion constructs of the present invention are effective agents useful in wound healing applications. In one embodiment, the TIMP is linked to mucin followed by GPI in order to enhance surface presentation. The use of GPI to link TIMP renders the resulting fusion protein particularly useful as an anti-cancer agent for the treatment of cancer, and, in particular, any residual cancer following an incomplete surgical resection of primary tumors in an individual.


Find Patent Forward Citations

Loading…